Michael Thomas Heffernan - Net Worth and Insider Trading

Michael Thomas Heffernan Net Worth

The estimated net worth of Michael Thomas Heffernan is at least $899,192 dollars as of 2024-11-13. Michael Thomas Heffernan is the Director of Collegium Pharmaceutical Inc and owns about 28,023 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $880,202. Michael Thomas Heffernan is also the Director of Trevi Therapeutics Inc and owns about 6,351 shares of Trevi Therapeutics Inc (TRVI) stock worth over $18,989. Details can be seen in Michael Thomas Heffernan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Thomas Heffernan has not made any transactions after 2022-12-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Thomas Heffernan

To

Michael Thomas Heffernan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Thomas Heffernan owns 8 companies in total, including Collegium Pharmaceutical Inc (COLL) , Trevi Therapeutics Inc (TRVI) , and Akebia Therapeutics Inc (AKBA) among others .

Click here to see the complete history of Michael Thomas Heffernan’s form 4 insider trades.

Insider Ownership Summary of Michael Thomas Heffernan

Ticker Comapny Transaction Date Type of Owner
COLL Collegium Pharmaceutical Inc 2022-12-27 director
TRVI Trevi Therapeutics Inc 2019-05-09 director
AKBA Akebia Therapeutics Inc 2018-12-12 director
LIMIT LIMIT 2020-01-31 director
LIMIT LIMIT 2018-12-12 director
LIMIT LIMIT 2016-02-10 director
LIMIT LIMIT 2020-12-08 director
LIMIT LIMIT 2022-10-03 director

Michael Thomas Heffernan Latest Holdings Summary

Michael Thomas Heffernan currently owns a total of 2 stocks. Among these stocks, Michael Thomas Heffernan owns 28,023 shares of Collegium Pharmaceutical Inc (COLL) as of December 27, 2022, with a value of $880,202 and a weighting of 97.89%. Michael Thomas Heffernan also owns 6,351 shares of Trevi Therapeutics Inc (TRVI) as of May 9, 2019, with a value of $18,989 and a weighting of 2.11%.

Latest Holdings of Michael Thomas Heffernan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2022-12-27 28,023 31.41 880,202
TRVI Trevi Therapeutics Inc 2019-05-09 6,351 2.99 18,989

Holding Weightings of Michael Thomas Heffernan


Michael Thomas Heffernan Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Thomas Heffernan has made a total of 7 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 25,041 shares on December 27, 2022, which brought Michael Thomas Heffernan around $590,467.

According to the SEC Form 4 filings, Michael Thomas Heffernan has made a total of 0 transactions in Trevi Therapeutics Inc (TRVI) over the past 5 years. The most-recent trade in Trevi Therapeutics Inc is the acquisition of 2,500 shares on May 9, 2019, which cost Michael Thomas Heffernan around $25,000.

Insider Trading History of Michael Thomas Heffernan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Thomas Heffernan Trading Performance

GuruFocus tracks the stock performance after each of Michael Thomas Heffernan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Thomas Heffernan is -40.12%. GuruFocus also compares Michael Thomas Heffernan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Thomas Heffernan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Thomas Heffernan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Thomas Heffernan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.69 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.6 LIMIT LIMIT LIMIT LIMIT LIMIT

Michael Thomas Heffernan Ownership Network

Ownership Network List of Michael Thomas Heffernan

No Data

Ownership Network Relation of Michael Thomas Heffernan

Insider Network Chart

Michael Thomas Heffernan Owned Company Details

What does Collegium Pharmaceutical Inc do?

Who are the key executives at Collegium Pharmaceutical Inc?

Michael Thomas Heffernan is the director of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .

Collegium Pharmaceutical Inc (COLL) Insider Trades Summary

Over the past 18 months, Michael Thomas Heffernan made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .

In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Collegium Pharmaceutical Inc Insider Transactions

No Available Data

Michael Thomas Heffernan Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Thomas Heffernan. You might contact Michael Thomas Heffernan via mailing address: C/o Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary Nc 27518.